Christopher B. Prentiss

Chief Accounting Officer, Adamas Pharmaceuticals (United States).

Companies

MannKind CorporationChief financial officer Apr 22, 2024 to now¹
Adamas Pharmaceuticals (United States)Chief financial officer Nov 8, 2019 to Nov 24, 2021²
Adamas Pharmaceuticals (United States)Chief Accounting Officer Sep 22, 2017 to Jul 23, 2019³

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jul 15, 2026Shares withheld for tax 10,675 shares at $4.09 of MannKind Corporation⁴
Jul 15, 2026Shares withheld for tax 11,572 shares at $4.09 of MannKind Corporation⁴
Apr 22, 2026Shares withheld for tax 12,267 shares at $2.74 of MannKind Corporation⁶
Mar 1, 2026Granted 5,000 shares at $3.27 of MannKind Corporation⁷
Jul 15, 2025Shares withheld for tax 11,540 shares at $3.85 of MannKind Corporation⁸
May 13, 2025Granted 119,000 shares of MannKind Corporation⁹
May 15, 2024Granted 129,000 shares of MannKind Corporation¹⁰
May 15, 2024Granted 103,600 shares of MannKind Corporation¹⁰
May 15, 2024Granted 103,600 shares of MannKind Corporation¹¹
Nov 24, 2021U 163,767 shares of Adamas Pharmaceuticals (United States)⁵
Nov 24, 2021Granted 18,750 shares of Adamas Pharmaceuticals (United States)⁵

The numbers on this page point here. Each one links to the record it came from.